Linde plc (EU)

  • WKN: A2DSYC
  • ISIN: IE00BZ12WP82
  • Land: Irland

Alle Mitteilungen

DGAP-Kapitalmarktinformation 23.11.21 09:48 DGAP-Kapitalmarktinformation: Linde plc (EU)
Linde plc: Release of a capital market information
DGAP-Kapitalmarktinformation 19.11.21 18:25 DGAP-Kapitalmarktinformation: Linde plc (EU)
Linde plc: Release according to Article 50 of the WpHG [the Ge[...]
DGAP-Kapitalmarktinformation 16.11.21 13:57 DGAP-Kapitalmarktinformation: Linde plc (EU)
Linde plc: Release of a capital market information
DGAP-DD 12.11.21 18:12 DGAP-DD: Linde plc (EU)
DGAP-DD: Linde plc english
DGAP-Stimmrechtsanteile 11.11.21 17:08 DGAP-Stimmrechtsanteile: Linde plc (EU)
Linde plc: Release according to Article 40, Section 1 of the W[...]
DGAP-Kapitalmarktinformation 09.11.21 12:26 DGAP-Kapitalmarktinformation: Linde plc (EU)
Linde plc: Release of a capital market information
DGAP-DD 05.11.21 21:21 DGAP-DD: Linde plc (EU)
DGAP-DD: Linde plc english
DGAP-DD 05.11.21 21:14 DGAP-DD: Linde plc (EU)
DGAP-DD: Linde plc english
DGAP-DD 04.11.21 21:56 DGAP-DD: Linde plc (EU)
DGAP-DD: Linde plc english
DGAP-Kapitalmarktinformation 02.11.21 12:01 DGAP-Kapitalmarktinformation: Linde plc (EU)
Linde plc: Release of a capital market information
DGAP-Kapitalmarktinformation 29.10.21 18:42 DGAP-Kapitalmarktinformation: Linde plc (EU)
Linde plc: Release according to Article 50 of the WpHG [the Ge[...]
DGAP-News 28.10.21 11:59 DGAP-News: Linde plc (EU)
Linde plc: Linde Reports Third-Quarter 2021 Results (Earnings [...]
DGAP-Kapitalmarktinformation 26.10.21 23:15 DGAP-Kapitalmarktinformation: Linde plc (EU)
Linde plc: Release according to Article 50 of the WpHG [the Ge[...]
DGAP-Kapitalmarktinformation 26.10.21 10:15 DGAP-Kapitalmarktinformation: Linde plc (EU)
Linde plc: Release of a capital market information
DGAP-News 25.10.21 17:30 DGAP-News: Linde plc (EU)
Linde plc: Linde Declares Dividend in Fourth Quarter 2021
DGAP-News 25.10.21 16:44 DGAP-News: Linde plc (EU)
Linde plc: Linde Board Elects Two New Directors and Adds Susta[...]
DGAP-News 25.10.21 16:37 DGAP-News: Linde plc (EU)
Linde plc: Linde Announces CEO and Chairman Succession
DGAP-Ad-hoc 25.10.21 16:34 DGAP-Ad-hoc: Linde plc (EU)
Linde plc Announces CEO and Chairman Succession
DGAP-News 21.10.21 12:00 DGAP-News: Linde plc (EU)
Linde Starts Up Major New Hydrogen Facility in the U.S. Gulf C[...]
DGAP-Kapitalmarktinformation 19.10.21 14:44 DGAP-Kapitalmarktinformation: Linde plc (EU)
Linde plc: Release of a capital market information

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktuelle Research-Studie

3U HOLDING AG

Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021